CAGNONI PABLO J

INCY President R&D sells 18,667 shares at $96.50; retains 262,692 shares; stock down 13.0% from 52-week high, up 6.0% in 30 days

CAGNONI PABLO J, President and Global Head of R&D, sold 18,667 shares of INCYTE CORP at $96.50, reducing holdings to 262,692 shares and maintaining a substantial position. The sale occurred as the stock trades 13.0% below its 52-week high of $110.57 despite a recent 6.0% 30-day gain, suggesting the sale was executed during a partial recovery from recent weakness. His prior two sales at INCY—on 2026-03-17 and 2026-02-19—resulted in mixed near-term price action (up 1.2% and down 10.0% respectively over the following 30 days), with no measurable 90-day outcomes yet, offering limited insight into his timing acuity at this ticker. The company exhibits solid fundamentals with $1.4B quarterly revenue, a 21.2% annual growth rate, and a low 7.84 P/E ratio, providing no obvious operational distress signal.

INCY President Pablo Cagnoni sells 18.7K shares ($1.8M) at $94.24; retains 234.8K shares post-transaction

Pablo Cagnoni, President of R&D at Incyte, sold 18,667 shares at $94.24 on 2026-03-17 for $1,759,178.08, reducing his holdings by 7.4% to 234.8K shares. The sale occurred as INCY stock has declined 8.1% over the past 30 days and 9.5% over 90 days, trading 15.9% below its 52-week high of $110.57. Cagnoni's cross-ticker track record shows only 1 prior open-market sell, and his only prior trade at INCY occurred on 2026-02-19 (a sell whose timing outcome is not yet measurable). The company's fundamentals remain solid with $1.4B in latest-quarter revenue, $424.2M net income, and 21.2% annual revenue growth, though the stock's recent price weakness and the insider's continued substantial holdings suggest no imminent distress signal.

INCY President of R&D sells 18,668 shares at $100.91; retains 234,800 shares after 7.4% reduction

Pablo J. Cagnoni, President of R&D at Incyte, sold 18,668 shares on 2026-02-19 at $100.91, reducing holdings from 253,468 to 234,800 shares. The sale occurred near the 52-week high of $110.57, with current price at $100.84 representing an 8.8% decline from the peak. Despite the reduction in share count, Cagnoni maintains substantial holdings of 234,800 shares, indicating continued material ownership stake in the company. Incyte's fundamentals remain solid with annual revenue growth of +21.2%, a net income of $424,169,000, and a P/E of 8.22, providing no obvious deterioration that would explain the sale at this timing relative to recent price momentum.